medigraphic.com

2014, Number S2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (S2)

Chromosomal imbalances and survival in patients with astrocytomas

López-Aguilar E, Rioscovian-Soto A, Betanzos-Cabrera Y, Ruiz-Esparza R, Sepúlveda-Vildósola AC

Language: Spanish
References: 18
Page: 98-103
PDF size: 102.11 Kb.


ABSTRACT

Background: Cytogenetics has revealed that the development of brain tumors might be induced by molecular alterations. The association of chromosomal imbalances with survival will allow for the prognosis and treatment of these tumors to be assessed. The objective of this study was to determine chromosomal imbalances and overall and diseasefree survival in pediatric patients with astrocytoma and the association between chromosomal imbalances and survival.
Methods: Medical charts of patients diagnosed with astrocytoma according to records from 1995 to 2005 were reviewed. Paraffi n blocks were retrieved in order to extract tumor material and a comparative genomic hybridization technique was used to search for chromosomal gains and losses.
Results: Out of 35 patients, 31 had at least some alteration in chromosomes 1, 5, 9 or 18, the latter with gains or losses in 65.7 % of the patients. By histology, 7/9 pilocytic astrocytomas had alteration of chromosome 9, and in 5/6 anaplastic astrocytomas, of chromosome 18. Patients with alterations in these chromosomes had a worse survival.
Conclusions: The results of this study suggest that there is an association between the anaplastic histology and chromosome 18 alterations, as well as between diffuse astrocytoma and alterations in chromosome 5, which could be relevant in the Latin American population.


REFERENCES

  1. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007; 25(4): 867-90, vii.

  2. Cuevas-Urióstegui ML, Villasís-Keever MA, Fajardo- Gutiérrez A. Epidemiología del cáncer en adolescentes. Salud Publica Mex. 2003;45(Supl 1):115-23.

  3. Dirección General de Epidemiología. Compendio del Registro Histopatológico de Neoplasias en México. Morbilidad, regionalización 1993-1996 y mortalidad. Tendencias 1985-1995, México: Secretaría de Salud; 1998.

  4. Gutmann D, James CD, Poyhonen J, Louis DN, Ferner R, Guha A, et al. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology. 2003;61(10):1397-400.

  5. López-Aguilar E, Sepúlveda-Vildósola AC, Betanzos- Cabrera Y, Gascón-Lastiri G, Ortiz-Suárez L, Rivera- Márquez H, et al. Prognostic and survival factors among pediatric patients with ependymomas. Gac Med Mex. 2009;145(1):7-13.

  6. Biegel JA. Cytogenetics and molecular genetics of childhood brain tumors. Neuro-Oncology. 1999;1(2):139-51.

  7. Rickert CH, Sträter R, Kaatsch P, Wassmann H, Jürgens H, Dockhorn-Dworniczak B, et al. Pediatric high-grade astrocytomaas show chromosomal imbalances distinct from adult cases. Am J Pathol. 2001;158(4):1525-32.

  8. Shirahata M, Oba S, Iwao-Koizumi K, Saito S, Ueno N, Oda M, et al. Using gene expression profi ling to identify a prognostic molecular spectrum in gliomas. Cancer Sci. 2009;100(1):165-172.

  9. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K. Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet. 1993;71(1):40-9.

  10. Moscatello DK, Holgado-Madruga M, Godwin AK, Ramírez G, Gunn G, Zoltick PW, et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 1995; 55(23):5536-9.

  11. Ward SJ, Karakoula K, Phipps KP, Harkness W, Hayward R, Thompson D, et al. Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridisation and fl uorescence in-situ hybridisation. J Neurooncol. 2010;98(3):305-18.

  12. Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martínez AJ, Sherwin RN, The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res.1993;57(2):304-9.

  13. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, et al. Identifi cation of gain and losses of DNA sequences in primary bladder cancer by comparative genomic hybidation. Genes Chromosome Cancer. 1995;12(3):213-9.

  14. Holland H, Koschny T, Ahnert P, Meixensberger J, Koschny R. WHO grade-specifi c comparative genomic hybridization pattern of astrocytoma - a metaanalysis. Pathol Res Pract. 2010;206(10):663-6.

  15. Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplifi cation sites and nonrandom chromosomal gains and losses. Am J Pathol. 1994;144(6):1203-18.

  16. Barrow J, Adamowicz-Brice M, Cartmill M, MacArthur D, Lowe J, Robson K. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric highgrade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol. 2011;13(2):212-22.

  17. Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG. Grade II astrocytomas are subgroupedby chromosoma aberratios. Cancer Genet Cytogenet. 2003;142(1):1-7

  18. Jin S, Sun C, Yu S, Wang Q, Wu W, Sun Y, Zhao W, An T. Chromosome DNA imbalances in human astrocytic tumors: A comparative genomic hybridization study of 63 Chinese patients. Pathol Res Pract. 2010;206(10):674-81.




2020     |     www.medigraphic.com